Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-18-000004

CEO acquired 32,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-08-31 Grant or award : show line 1 in the form +32,500 $2.07 $67,275 7,126,304 D
Loading xslF345X03/primary_doc.xml…